selective laser trabeculoplasty (SLT)

PSLT shows promise in lowering intraocular pressure Compared with SLT, PSLT appears to offer some advantages, such as a shorter duration of treatment and more comfort for patients.
Targeting dry eye in glaucoma patients
Targeting dry eye in glaucoma patientsA poor ocular surface is a common condition in glaucoma patients due to the incidence of dry eye, age, and use of benzalkonium chloride (BAK). Poor compliance with glaucoma therapy can result. Use of point-of-care testing can help identify patients with a poor ocular surface and drive treatment decisions. Treatment options, including surgical, are discussed.
NC ODs say laser privileges will expand access to care
Effects of concurrent use of topical, oral beta blockersRecently, I received a progress note from a glaucoma surgeon concerning a patient whom he and I share. The patient is a 58-year-old African-American female with a longstanding history of primary open-angle glaucoma.
Exploring SLT efficacy for prior incisional glaucoma surgerySelective laser trabeculoplasty is a reasonable treatment option to reduce IOP in glaucoma patients who have had previous glaucoma surgery.
Computer-guided treatment delivery builds on benefits of SLTPattern scanning laser trabeculoplasty uses computer guidance for precise delivery of laser spots to the trabecular meshwork. At 6 months post-treatment, percentage IOP reduction was similar in eyes undergoing PSLT performed with a 577-nm laser compared with selective laser trabeculoplasty using a 532-nm laser.